Arena Pharmaceuticals, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Arena Pharmaceuticals, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Arena Pharmaceuticals, Inc.. The Group's principal activities are to discover, develop and commercialize novel and improve orally available drugs that address major unmet medical needs. The Group develops and commercializes oral drugs in therapeutic areas like cardiovascular, central nervous system, inflammatory and metabolic diseases. The Group has active collaborations with two major pharmaceutical companies, Ortho-McNeil-Janssen Pharmaceuticals Inc, for the treatment of type 2 diabetes and Merck & Co Inc, for the treatment of atherosclerosis and related disorders. The Group has a pipeline of internally discovered small molecule drug candidates that target G protein-coupled receptors. The Group operates in the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report